Table 1.
Baseline patient characteristics
| Low stage/High stage TMA | Matched primary, metastasis TMA | Metastasis TMA | |
|---|---|---|---|
| Age at time of surgery |
60.1 |
49.8 |
52.9 |
| Percent female |
35.4 |
37.0 |
n/a |
| RCC subtype N (%) |
|
|
|
| Clear cell |
68 (82.9%) |
23 (85.2%) |
128 |
| Papillary |
12 (14.6%) |
3 (11.1%) |
5 |
| Percent > stage T1 |
37.8% |
n/a |
n/a |
| Percent > grade II |
28.0% |
44.4% |
n/a |
| Metastasis location |
n/a |
a |
|
|
Lymph node |
|
7 |
34 |
|
Bone |
|
1 |
25 |
|
Brain |
|
1 |
21 |
|
Lung |
|
3 |
20 |
|
Adrenal |
|
4 |
11 |
| Other | 3 | 18 |
aNot all locations were available from chart review.